SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015783
Filing Date
2018-11-13
Accepted
2018-11-13 17:01:24
Documents
67
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 745345
2 ex31-1.htm EX-31.1 12957
3 ex31-2.htm EX-31.2 13053
4 ex32-1.htm EX-32.1 8328
5 ex32-2.htm EX-32.2 8609
  Complete submission text file 0001493152-18-015783.txt   3636371

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cdxi-20180930.xml EX-101.INS 538555
7 XBRL SCHEMA FILE cdxi-20180930.xsd EX-101.SCH 47575
8 XBRL CALCULATION FILE cdxi-20180930_cal.xml EX-101.CAL 54432
9 XBRL DEFINITION FILE cdxi-20180930_def.xml EX-101.DEF 142095
10 XBRL LABEL FILE cdxi-20180930_lab.xml EX-101.LAB 332235
11 XBRL PRESENTATION FILE cdxi-20180930_pre.xml EX-101.PRE 250086
Mailing Address 2800 WOODLAWN DRIVE SUITE 129 HONOLULU HI 96822
Business Address 2800 WOODLAWN DRIVE SUITE 129 HONOLULU HI 96822 808-457-1400
CARDAX, INC. (Filer) CIK: 0001544238 (see all company filings)

IRS No.: 454484428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-181719 | Film No.: 181178889
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1